Globus Medical (GMED) Total Current Liabilities (2011 - 2026)
Globus Medical's (GMED) quarterly Total Current Liabilities came in at $482.5 million in Q1 2026, up 25.41% YoY from $384.7 million in Q1 2025, and down 3.22% on a QoQ basis from $498.5 million in Q4 2025.
Globus Medical (GMED) Total Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has 16 years of Total Current Liabilities data on file, last reported at $482.5 million in Q1 2026.
- Quarterly Total Current Liabilities rose 25.41% year-over-year to $482.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $482.5 million (up 25.41% YoY) and the FY2025 annual result came in at $498.5 million, down 41.76% from the prior year.
- Total Current Liabilities retreated to $482.5 million in Q1 2026, from $498.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $855.9 million in Q4 2024 to a low of $141.5 million in Q1 2022.
- A 5-year average of $426.3 million and a median of $424.7 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 411.63% — and 2025, when it plunged 51.08%.
- Tracing GMED's Total Current Liabilities over 5 years: stood at $159.2 million in 2022, then soared by 146.44% to $392.3 million in 2023, then surged by 118.15% to $855.9 million in 2024, then sank by 41.76% to $498.5 million in 2025, then fell by 3.22% to $482.5 million in 2026.
- The last three Total Current Liabilities figures came in at $482.5 million (Q1 2026), $498.5 million (Q4 2025), and $466.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Globus Medical | 11.70 Bn | 11.11 Bn | 548.17 Mn | 479.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 479.35 Mn |
| Mar 31, 2026 | 482.46 Mn |
| Dec 31, 2025 | 498.50 Mn |
| Sep 30, 2025 | 465.96 Mn |
| Jun 30, 2025 | 424.66 Mn |
| Mar 31, 2025 | 384.70 Mn |
| Dec 31, 2024 | 855.91 Mn |
| Sep 30, 2024 | 818.07 Mn |
| Jun 30, 2024 | 794.15 Mn |
| Mar 31, 2024 | 786.32 Mn |
| Dec 31, 2023 | 392.35 Mn |
| Sep 30, 2023 | 428.72 Mn |
| Jun 30, 2023 | 155.22 Mn |
| Mar 31, 2023 | 167.55 Mn |
| Dec 31, 2022 | 159.20 Mn |
| Sep 30, 2022 | 145.26 Mn |
| Jun 30, 2022 | 146.02 Mn |
| Mar 31, 2022 | 141.49 Mn |
| Dec 31, 2021 | 140.16 Mn |
| Sep 30, 2021 | 122.53 Mn |